ImageneBio Inc
General ticker "IMA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $316.2M (TTM average)
ImageneBio Inc does not follow the US Stock Market performance with the rate: -16.5%.
Estimated limits based on current volatility of 1.1%: low 4.54$, high 4.64$
Factors to consider:
- Total employees count: 15 (+50.0%) as of 2025
- Top business risk factors: Limited operating history, Need additional capital, Clinical trial failure, Regulatory and compliance, Manufacturing issues
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.33$, 9.04$]
- 2026-12-31 to 2027-12-31 estimated range: [2.29$, 6.20$]
Financial Metrics affecting the IMA estimates:
- Negative: with PPE of -1.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: -18.95 < Investing cash flow per share per price, % of -17.05
- Negative: negative Operating cash flow
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -22.87
- Negative: 0 < Industry inventory ratio change (median), % of 0
- Negative: Shareholder equity ratio, % of 87.03 > 81.92
Short-term IMA quotes
Long-term IMA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9.16MM | $3.50MM | $0.80MM |
| Operating Expenses | $84.58MM | $40.50MM | $49.25MM |
| Operating Income | $-75.42MM | $-37.00MM | $-48.45MM |
| Non-Operating Income | $7.09MM | $0.45MM | $2.75MM |
| R&D Expense | $59.65MM | $32.11MM | $28.52MM |
| Income(Loss) | $-68.33MM | $-36.55MM | $-45.70MM |
| Taxes | $-0.16MM | $0.01MM | $-0.35MM |
| Net Income(Loss)* | $-68.17MM | $-49.23MM | $-45.35MM |
| Stockholders Equity | $169.76MM | $125.93MM | $133.14MM |
| Assets | $192.09MM | $141.51MM | $152.98MM |
| Operating Cash Flow | $-79.74MM | $-21.32MM | $-47.84MM |
| Capital expenditure | $0.41MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $64.14MM | $11.12MM | $-5.81MM |
| Financing Cash Flow | $75.98MM | $6.91MM | $135.47MM |
| Earnings Per Share** | $-19.60 | $-41.23 | $-8.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.